About Us

The British Sarcoma Group is led by a multidisciplinary team of clinicians, researchers, nurses, and patient advocates who work together to advance sarcoma care, share expertise, and shape national best practice.

Treating Sarcoma

Adult sarcoma

In England and Wales the “Improving Outcomes Guidance” (IOG) from the NHS regulator NICE, published in 2006, provides the underlying principles for the organisation of sarcoma services. Soft tissue and bone sarcomas should be treated under the care of a sarcoma Multi-Disciplinary Team at a specialist sarcoma centre. There are five nationally-commissioned centres for treatment of bone sarcomas.

Treatment standards in England are determined by the peer review programme introduced by the National Cancer Action Team to monitor the effect of the NICE Improving Outcomes Guidance (IOG) for People. (Download NICE IOG)

In Scotland the Scottish Sarcoma Network is one of the national managed cancer treatment networks, and brings together the five sarcoma treatment centres. In Northern Ireland, the specialist clinicians are based in Belfast.

Paediatric and teenage sarcoma

Sarcoma in children will be treated according to the protocols of the Children Cancer and Leukaemia Group whose centres across the UK specialise in children’s cancers. Teenage sarcoma is also treated in specialist units, where these are available, and usually by the same surgeons and oncologists who treat children and adults.

For England and Wales surgery for bone sarcomas is undertaken in one of the five nationally funded centres indicated above but other treatment may be in a paediatric or teenage unit.

The aims of the BSG

1. To promote the education of medical, nursing and healthcare professionals in the UK concerned with the treatment and care of patients with bone and soft tissue sarcomas through the provision of information, training, and the identification of best practice

2. To promote excellence in the healthcare and treatment of patients with bone and soft tissue sarcoma, through enabling specialist healthcare professionals to identify and share best practice

3. To promote and support research, including the publication of results to support the development of more effective treatment and care of patients with bone and soft tissue sarcomas

4. To improve the knowledge and understanding of sarcoma amongst the medical profession and general public.

Board of Trustees

Routine administration of the charity and conference management is undertaken by the Secretariat who can be contacted at support@britishsarcomagroup.org.uk or on 0191 244 2581. Our board of trustees is made up of senior sarcoma specialists from all areas of sarcoma care. If you are interested in joining the board of trustees please contact  support@britishsarcomagroup.org.uk for more information.

Anant Desai

Anant Desai

President

Consultant Surgeon, Queen Elizabeth Hospital Birmingham

Read more about Anant
Adam Dangoor

Adam Dangoor

Past President

Medical Oncologist, University Hospitals Bristol NHS Trust

Read more about Adam
Andrew Hayes

Andrew Hayes

Surgical Oncologist, Royal Marsden Hospital

Read more about Andrew
Alex Lee

Alex Lee

Consultant Medical Oncologist, Leeds Teaching Hospitals NHS Trust

Read more about Alex
Charlotte Benson

Charlotte Benson

Consultant Medical Oncologist, Royal Marsden Hospital

Read more about Charlotte
Christine Millman

Christine Millman

Sarcoma CNS, North Bristol NHS Trust Southmead Hospital

Read more about Christine
Debbie Artis

Debbie Artis

Sarcoma Physiotherapist, Leeds Teaching Hospitals NHS Trust

Read more about Debbie
Johanne Vass

Johanne Vass

Sarcoma Advanced Nurse Practitioner, Swansea Bay University Health Board

Read more about Johanne
Michael Parry

Michael Parry

Consultant Orthopaedic Surgeon, Royal Orthopaedic Hospital, Birmingham

Read more about Michael
Sherron Furtado

Sherron Furtado

Senior Sarcoma Research Therapist, Royal National Orthopaedic Hospital

Read more about Sherron
Sian Alsousou

Sian Alsousou

Sarcoma CNS, Liverpool University Hospitals

Read more about Sian

Anant Desai is a Consultant Surgeon at the Queen Elizabeth Hospital Birmingham, specialising in complex sarcoma and soft‑tissue oncology. He is recognised for his patient‑centred approach, commitment to multidisciplinary care, and contributions to advancing surgical techniques within his field. Alongside his clinical work, Anant plays an active role in research, education, and service development, helping to shape high‑quality care pathways for patients across the region.

Adam Dangoor is a Medical Oncologist at University Hospitals Bristol NHS Trust, specialising in the treatment of sarcoma and rare cancers. He is dedicated to delivering compassionate, evidence‑based care and plays a key role in regional multidisciplinary services. Adam is actively involved in clinical research and national collaborative initiatives aimed at improving outcomes for patients with complex cancers. He also contributes to education and service development, helping to advance oncology practice across the UK.

Andrew Hayes is a Surgical Oncologist at the Royal Marsden Hospital, specialising in the management of soft‑tissue and complex sarcoma cases. He is known for his meticulous surgical expertise, collaborative approach within multidisciplinary teams, and commitment to delivering personalised cancer care. Andrew is actively engaged in research and clinical innovation, contributing to developments in oncologic surgery and improving pathways for patients with rare and challenging tumours. He also supports education and training initiatives to advance surgical practice in the UK.

Alex Lee is a Consultant Medical Oncologist at Leeds Teaching Hospitals NHS Trust, specialising in the management of sarcoma and complex rare cancers. He is committed to delivering personalised, evidence‑led care and plays a key role in multidisciplinary cancer services across the region. Alex is actively involved in clinical research and contributes to national collaborative studies aimed at improving therapeutic outcomes. Alongside his clinical work, he supports education and service development initiatives to advance oncology practice in the UK.

Charlotte Benson is a Consultant Medical Oncologist at the Royal Marsden Hospital, specialising in the treatment of sarcoma and rare cancers. She is recognised for her evidence‑based, compassionate approach to patient care and her strong involvement in multidisciplinary team management. Charlotte contributes extensively to clinical research and national oncology initiatives, helping to advance therapies and improve outcomes for patients with complex malignancies. She is also active in education and training, supporting the development of future oncology specialists.

Christine Millman is a Sarcoma Clinical Nurse Specialist at North Bristol NHS Trust, based at Southmead Hospital. She provides expert support to patients throughout their sarcoma treatment pathway, offering clinical guidance, compassionate care, and continuity across multidisciplinary services. Christine plays a key role in patient education, service coordination, and improving the overall experience for individuals living with rare cancers. She is committed to advancing sarcoma care through ongoing professional development and collaboration with regional and national teams.

Debbie Artis is a Sarcoma Physiotherapist at Leeds Teaching Hospitals NHS Trust, specialising in rehabilitation for patients undergoing treatment for sarcoma and complex musculoskeletal cancers. She provides tailored physiotherapy programmes aimed at restoring function, improving mobility, and enhancing quality of life throughout the treatment pathway. Debbie works closely within multidisciplinary teams to ensure coordinated, patient‑centred care. She is committed to service development, patient education, and advancing rehabilitation practices to support individuals living with rare and challenging conditions.

Johanne Vass is a Sarcoma Advanced Nurse Practitioner at Swansea Bay University Health Board, providing specialist expertise and compassionate support to patients throughout their sarcoma care journey. With a strong focus on personalised care, she coordinates treatment pathways, offers clinical guidance, and plays an integral role within the multidisciplinary team. Johanne is committed to service improvement, patient education, and advancing sarcoma nursing practice across the region.

Michael Parry is a Consultant Orthopaedic Surgeon at the Royal Orthopaedic Hospital, Birmingham, specialising in the management of bone and soft‑tissue sarcomas. He is highly regarded for his expertise in complex limb‑sparing surgery, reconstruction, and personalised patient care. Michael plays an integral role in the multidisciplinary sarcoma service and contributes extensively to clinical research and surgical innovation. He is committed to improving outcomes for patients with rare musculoskeletal tumours and to advancing orthopaedic oncology practice through education and national collaboration.

Sherron Furtado is a Senior Sarcoma Research Therapist at the Royal National Orthopaedic Hospital, where she plays a key role in delivering and supporting clinical research for patients with sarcoma. With extensive experience in specialised rehabilitation and research coordination, Sherron works closely with multidisciplinary teams to improve patient outcomes and advance evidence‑based practice. She is committed to enhancing the patient experience, contributing to innovative studies, and helping to shape future developments in sarcoma care and therapy.

Sian Alsousou is a Sarcoma Clinical Nurse Specialist at Liverpool University Hospitals, providing dedicated support to patients throughout their sarcoma diagnosis, treatment, and recovery. She plays a central role in coordinating care, offering expert clinical guidance, and ensuring a compassionate, patient‑centred approach across the multidisciplinary team. Sian is committed to improving patient experience, advancing sarcoma nursing practice, and contributing to service development within the regional sarcoma network.